CPHI יחס מהיר China Pharma Holdings Inc.

China Pharma Holdings (CPHI) is expanding the production of psychoneurological agents and branded generic drugs, aiming to capture new market shares through B2B sales to pharmacy chains. The market dynamics reflected in the price action, where the indicator stands at 0.08, demonstrate the impact of US-China trade conflicts restricting access to Western capital. Business stability is ensured by a wide circle of local raw material suppliers, which mitigates production disruptions.

The quick ratio measures a company's ability to instantaneously settle short-term liabilities without liquidating inventory. The calculation is based on comparing cash and accounts receivable against current debts to assess protection against cash flow gaps. The history of quick liquidity indicators reflects the financial stability dynamics of China Pharma Holdings (CPHI). For an issuer focused on the operational efficiency of its factories, this metric confirms the quality of liquidity management given the baseline level of reporting transparency.